Home/Pipeline/Endometriosis Test Suite

Endometriosis Test Suite

Endometriosis

Pre-clinicalActive

Key Facts

Indication

Endometriosis

Phase

Pre-clinical

Status

Active

Company

Heranova Lifesciences

About Heranova Lifesciences

Heranova Lifesciences is a private, early-stage diagnostics company targeting significant unmet needs in women's health. The company has launched its first commercial product, HerResolve™, a non-invasive blood test for the detection and confirmation of endometriosis, which is being rolled out at select US fertility clinics. Heranova is positioned in a large and underserved market, aiming to reduce the diagnostic delay for endometriosis and improve fertility treatment planning. The company appears to be in an early revenue-generating phase as it commercializes its initial test while developing a broader pipeline of diagnostics and potential treatments.

View full company profile

Therapeutic Areas

Endometriosis Female Infertility

Other Endometriosis Drugs

Drug	Company	Phase	Status
Promarker™Endo	Proteomics International	Late‑stage validation	Active
EV‑Endo	Cartherics	Preclinical	Active
Endometriosis Program	Cyclana Bio	Discovery	Active
Endometriosis Genetic Study	Juneau Biosciences	Discovery	Active
Potential Diagnostic Development	Juneau Biosciences	Research	Active
Endometriosis Discovery Program	Metri Bio	Discovery	Active
EndomTest	Kephera Diagnostics	Commercial (LDT)	Active
ENDO-205	EndoCyclic Therapeutics	Phase 1	Active
Undisclosed Immunotherapy	Apheon Bioscience	Preclinical	Active
FMC	FimmCyte	Pre-clinical	Active
ABC-201	Abcely	Preclinical	Active
ERβ Modulator Program	Cadenza Bio	Preclinical	Active